2m 2m 2m 2m 2m 2m 2m
Geron (GERN)
NASDAQ
$1.37+$0.01 (+1.11%)
Price as of Sep 11, 2026 7:59 PM EDT- $867.3MMarket Cap
- 6.30%1-Year Change
- BiotechnologyIndustry
Geron (GERN)
$1.37+$0.01 (+1.11%)
GERN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.35 | ||
Change | -$0.02 (-1.46%) | ||
Open | $1.39 | ||
High | $1.41 | ||
Low | $1.34 | ||
Previous Close | $1.37 | ||
Volume | 14,722,266 | ||
30-Day Average Volume | 9,689,404 | ||
1-Week Change | -14.01% | ||
1-Month Change | -17.18% | ||
1-Year Change | 6.30% | ||
3-Year Change | -42.31% | ||
5-Year Change | -4.93% | ||
Fundamentals | |||
Shares Outstanding | 642.5M | ||
Total Assets | $519.0M | ||
Market Cap | $867.3M | ||
Enterprise Value | $924.8M | ||
Period: QTR TTM FY | |||
Revenue | $57.5M | ||
Net Income | -$16.7M | ||
Free Cash Flow | -$15.8M | ||
EBIT | -$12.5M | ||
EBITDA | -$12.3M | ||
Net Working Capital | $416.0M | ||
EPS | -$0.02 | ||
Enterprise Value/EBITDA | -75 | ||
Enterprise Value/Revenue | 16 | ||
P/B | 4 | ||
P/E | -68 | ||
PEG | 1 | ||
Price/Free Cash Flow | -55 | ||
Price/Operating Cash Flow | -55 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue